Echocardiography in Nursing Home
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Implementation of echocardiography in nursing homes.
- Who it may be relevant to
- Registry conditions: Heart Diseases, Heart Failure, Heart Valve Diseases. Basic parameters: from 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Implementation and Effectiveness of Screening Echocardiography Performed in Nursing Home: ECHOGER
Overview
The study seeks to explore the implementation characteristics (acceptability, appropriateness, feasibility, adoption, fidelity, penetration, implementation cost and sustainability) of systematic echocardiography in nursing homes and its impact on rates of heart failure flare-up and unscheduled hospitalization at 12 months among included nursing homes.
Detailed description
Open-label cluster randomized type 1 hybrid trial, with 2 parallel arms: nursing homes will be randomized in the interventional (echocardiography by sonographer) or non-interventional arms (usual care). In the interventional arm echocardiography will be proposed to all residents of the nursing home at baseline. Clinical management will be adapted to the result of echocardiography by the general practitioner, in accordance with the cardiologist. The main objective is to assess the impact at 12 months of the initial performance of a systematic simplified echocardiography on the rate of nursing home residents presenting with heart failure episode or cardiovascular pathology. The Primary endpoint is the number of nursing home residents presenting a heart failure episode or an unscheduled hospitalization for heart failure or other cardiovascular pathologies at 12 months.
Thirty nursing homes and 1050 residents will be included overall
Interventions
- Diagnostic test Implementation of echocardiography in nursing homes
An ultrasound will be carried out in the EHPAD, the result of which will be interpreted by a cardiologist then sent to the establishment and the attending physician with instructions to follow.
Primary outcome measures
- Count of resident presenting a heart failure decompensation [Time frame: 12 months]
Secondary outcome measures (1)
- Presence of a clinically significative change in medical management and care in the month following ultrasound [Time frame: 12 months]
Eligibility criteria
Inclusion criteria
Nursing homes residents with a life-expectancy estimated > 1 year, and able to participate to the study, giving an oral consent
Exclusion criteria
- no accessible to echocardiography
- closed unit (severe Alzheimer disease…)
- recent contagious disease such Covid (<15 days)
- no consent to participate
- no social security number
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Screening
Study locations
France · 1 center
- Nantes University Hospital — Nantes
Identifiers
NCT: NCT06445231 · RC22_0449